Table III.

Comparison of study endpoints and adverse events

Study endpoints	< 130/80 mm Hg (n = 366)	< 140/90 mm Hg (n = 570)	≥ 140/90 mm Hg (n = 290)
All-cause mortality, n (%)	0	0	1 (0.3)
Non-fatal MI, n (%)	2 (0.5)	8 (1.4)	6 (2.1)
Ischemic stroke/TIA, n (%)	5 (1.4)	12 (2.1)	11 (3.8)*#
Composite, n (%)	7 (1.9)	20 (3.5)	18 (6.2)*#
Falling down, n (%)	2 (0.5)	0	1 (0.3)
GFR [ml/min/1.73 m2]	78.0 ±9.6	75.4 ±11.2	73.4 ±10.1*

^*P < 0.01 vs. < 130/80 mm Hg group;

^#p < 0.05 vs. < 140/90 mm Hg group;

GFR – glomerular filtration rate.